Breast reconstruction is fundamental and urgent for patients in order to avoid future psychological and physical issues. That’s why immediate breast reconstruction has been requested increasingly in the last years. In this study two prosthesis with different structures and properties were compared according the aesthetic appearance (BREAST-Q© was employed) and five complications (seroma, hematoma, infections, dehiscence and red breast syndrome). The overall population was composed by 56 patients: 24 received a Tutomesh prosthesis and 32 received a Surgimend prosthesis. The DMAIC (define, measure, analyse, improve and control) cycle was implemented as a problem-solving strategy of the Six Sigma to compare the prostheses. While statistically significant difference between the two groups wasn’t found according to the overall BREAST-Q© (p-value = 0.674), the number of complications of the two groups resulted statistically different (p-value of chi-square test less than 0.001). Although it is not possible to understand from this study the reasons of the differences between the complications, this research proved that Surgimend and Tutomesh prostheses can be both implanted safely for immediate breast reconstruction since the higher costs of Surgimend could be neutralized with its lower hospitalization compared to Tutomesh.

The Use of Six Sigma to Assess Two Prostheses for Immediate Breast Reconstruction / Ricciardi, C.; Gubitosi, A.; Lanzano, G.; Pieretti, G.; Improta, G.; Crisci, E.; Ferraro, G. A.. - 80:(2021), pp. 1112-1120. ( 8th European Medical and Biological Engineering Conference, EMBEC 2020 Portorož 29 Novembre - 3 Dicembre 2020) [10.1007/978-3-030-64610-3_125].

The Use of Six Sigma to Assess Two Prostheses for Immediate Breast Reconstruction

Ricciardi C.;Gubitosi A.;Improta G.;
2021

Abstract

Breast reconstruction is fundamental and urgent for patients in order to avoid future psychological and physical issues. That’s why immediate breast reconstruction has been requested increasingly in the last years. In this study two prosthesis with different structures and properties were compared according the aesthetic appearance (BREAST-Q© was employed) and five complications (seroma, hematoma, infections, dehiscence and red breast syndrome). The overall population was composed by 56 patients: 24 received a Tutomesh prosthesis and 32 received a Surgimend prosthesis. The DMAIC (define, measure, analyse, improve and control) cycle was implemented as a problem-solving strategy of the Six Sigma to compare the prostheses. While statistically significant difference between the two groups wasn’t found according to the overall BREAST-Q© (p-value = 0.674), the number of complications of the two groups resulted statistically different (p-value of chi-square test less than 0.001). Although it is not possible to understand from this study the reasons of the differences between the complications, this research proved that Surgimend and Tutomesh prostheses can be both implanted safely for immediate breast reconstruction since the higher costs of Surgimend could be neutralized with its lower hospitalization compared to Tutomesh.
2021
978-303064609-7
The Use of Six Sigma to Assess Two Prostheses for Immediate Breast Reconstruction / Ricciardi, C.; Gubitosi, A.; Lanzano, G.; Pieretti, G.; Improta, G.; Crisci, E.; Ferraro, G. A.. - 80:(2021), pp. 1112-1120. ( 8th European Medical and Biological Engineering Conference, EMBEC 2020 Portorož 29 Novembre - 3 Dicembre 2020) [10.1007/978-3-030-64610-3_125].
File in questo prodotto:
File Dimensione Formato  
Ricciardi2021_Chapter_TheUseOfSixSigmaToAssessTwoPro.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 328.63 kB
Formato Adobe PDF
328.63 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/855821
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 0
social impact